|
[1]
|
CXCR4-targeted PET imaging of glioblastoma using [68Ga]Ga-TD-01: from pharmacokinetics and dosimetry to theranostic potential
EJNMMI Radiopharmacy and Chemistry,
2026
DOI:10.1186/s41181-026-00457-9
|
|
|
|
|
[2]
|
Low-cost robotic manipulation of live microtissues for cancer drug testing
Science Advances,
2025
DOI:10.1126/sciadv.ads1631
|
|
|
|
|
[3]
|
Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studies
Pharmaceutical Statistics,
2024
DOI:10.1002/pst.2399
|
|
|
|
|
[4]
|
Gel-forming therapeutic peptide exhibits sustained delivery and efficacy in a mouse model of triple-negative breast cancer
Peptides,
2023
DOI:10.1016/j.peptides.2023.171075
|
|
|
|
|
[5]
|
Probing spatiotemporal fractionation on the preclinical level
Physics in Medicine & Biology,
2020
DOI:10.1088/1361-6560/abbb75
|
|
|
|
|
[6]
|
Multimodal molecular 3D imaging for the tumoral volumetric distribution assessment of folate-based biosensors
Medical & Biological Engineering & Computing,
2018
DOI:10.1007/s11517-017-1755-2
|
|
|
|
|
[7]
|
MRI Contrast Enhancement Using Ferritin Genes and Its Application for Evaluating Anticancer Drug Efficacy in Mouse Melanoma Models
Applied Magnetic Resonance,
2017
DOI:10.1007/s00723-017-0926-5
|
|
|
|
|
[8]
|
Monitoring the Growth of an Orthotopic Tumour Xenograft Model: Multi-Modal Imaging Assessment with Benchtop MRI (1T), High-Field MRI (9.4T), Ultrasound and Bioluminescence
PLOS ONE,
2016
DOI:10.1371/journal.pone.0156162
|
|
|
|